Deals Of The Week: Amgen/Watson, Baxter/Momenta, Takeda/Intellikine
Executive Summary
Biosimilars took center stage during the last two weeks of 2011, as Amgen and Watson and then Baxter and Momenta followed up on the collaboration between Biogen Idec and Samsung BioLogics earlier in the month.